Last updated on July 2019

A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis

---

Brief description of study

The study will investigate the efficacy and safety of an oral dose of AJM300 960 milligram (mg)/dose administered three times daily for 8 weeks in participants with active ulcerative colitis.